Zephyrus’ next-gen western blotting tech acquired by Bio-Techne
Zephyrus, a QB3 and Stanford StartX alum, has been building protein analysis tools for research.
Zephyrus’ next-gen Western blotting brings protein analysis to cellular level
A Bay Area company that allows protein analysis at the single cell level has raised $1.86 million in funding. Zephyrus Biosciences plans to develop and commercialize its single cell Western blotting system, called the scWestern system, that allows researchers to study proteins in thousands of single cells, the company said in a release. In June, it published […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.